drugset / Trial / NCT02834858

Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular Complications

NCT02834858

RandomizedParallel-groupOpen-labelTreatment

Summary

Stem cell therapy has been a new and effective therapy in recent years for diabetic foot.This study intends to establish an optimal clinical research program, and attempts to break the technical bottleneck in the stem cell therapy for treating diabetes related vascular complications.

Timeline

Start
2016-01
Primary completion
2018-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy